Tags : Oncology

Ibex Medical Analytics Raises $38 Million to Accelerate Adoption of

Ibex’s AI technology helps physicians and providers diagnose cancer with greater real-time accuracy by reducing error and misdiagnosis  Ibex Medical Analytics, the pioneer in AI-powered cancer diagnostics, today announced a $38 million Series B financing round led by Octopus Ventures and 83North, with additional participation from aMoon, Planven Entrepreneur Ventures and Dell Technologies Capital, the corporate venture […]Read More

Vidence and NTT DATA Announce Partnership to Deliver Predictive Analytics

Vidence, an oncology informatics company, and NTT DATA Services, a global digital business and IT services leader, today announced a relationship to build advanced artificial intelligence (AI) and machine learning (ML) algorithms to predict patient outcomes, enhance decision-making, and drive clinical trials to advance cancer research and treatment. This unique collaboration will utilize a combination […]Read More